Phocas Financial Corp’s United Therapeutics UTHR Stock Holding History

Phocas Financial Corp’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-89,549	Closed	-$15.4M	–	261
2015 Q1	$15.4M	Buy	89,549 +14,417	+19%	+$2.2M	1.23%	4
2014 Q4	$9.73M	Sell	75,132 -3,001	-4%	-$387K	0.85%	17
2014 Q3	$10.1M	Buy	78,133 +2,211	+3%	+$228K	0.9%	19
2014 Q2	$6.72M	Buy	75,922 +9,757	+15%	+$938K	0.59%	76
2014 Q1	$6.22M	Sell	66,165 -4,981	-7%	-$509K	0.6%	75
2013 Q4	$8.04M	Sell	71,146 -780	-1%	-$70.3K	0.74%	35
2013 Q3	$5.67M	Buy	71,926 +2,809	+4%	+$205K	0.55%	72
2013 Q2	$4.55M	Buy	+69,117	New	+$4.45M	0.48%	91

Other funds holding UTHR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Phocas Financial Corp's UTHR Position: Q2 2015 in Review

Phocas Financial Corp sold out of United Therapeutics (UTHR) in Q2 2015, closing a stake of 89,549 shares — an estimated $15.4M sold.

Phocas Financial Corp first reported a position in UTHR in Q2 2013 and held it in 8 quarters. The position peaked at $15.4M in Q1 2015. 384 funds tracked by Wall St. Rank hold UTHR as of Q2 2015.

Phocas Financial Corp reported no remaining United Therapeutics position as of Q2 2015 after selling out during the quarter.
Phocas Financial Corp sold 89,549 United Therapeutics shares in Q2 2015, an estimated $15.4M.
Phocas Financial Corp first reported a position in United Therapeutics in Q2 2013 and held it in 8 quarters.
Phocas Financial Corp's United Therapeutics position peaked at $15.4M in Q1 2015.
384 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2015.

Based on Phocas Financial Corp's 13F filing for Q2 2015, filed 12 Aug 2015.